The present study was undertaken t o define the umbilical cord plasma concentrations o f cholesterol throughout human gestation. Mixed a r t e r i a l and venous cord plasma samples obtained from abortuses of women undergoing e l e c t i v e abortion o r from infants of women who underwent spontaneous premature vaginal delivery, and from i n f a n t s o f women who delivered vaginally a t term were assayed f o r cholesterol by a micro-enzymatic method. No cases t h a t involved any maternal o r fetal complications (other than prematurity) were included i n t h i s study. Early i n gestation (10-16 weeks post-conception), the t o t a l cholesterol l e v e l i n cord plasma was 85.4 + 30.7 mg/dl (mean t SD), n = 68, w i t h the cholesterol l e v e l s i n some samples f a l l i n g w i t h i n the range of those o f adults. Between 16.5 and 20 weeks post-conception, the umbilical cord plasma cholesterol l e v e l declined t o 39.9 t 21.0 mgldl, n = 19 (P < 0.001 ).
INTRODUCTION
A d e f i n i t i o n o f the genetic and n u t r i t i o n a l regulation of cholesterol synthesis and metabolism i s believed t o be o f signal importance i n the development of r a t i o n a l approaches i n the prevention o f a r t e r i o s c l e r o t i c cardiovascular disorders. Generally the l e v e l s of cholesterol i n plasma of a d u l t humans are hioher than those i n olasma o f other mammalian soecies w i t h the exceotion o f aq;atic mamnals and hibernators (7,22).
These differences are due p;imarily t o higher l e v e l s o f low density 1 ipoprotein (LDL) i n humans; i n man LDL i s the p r i n c i p a l l i p o p r o t e i n f o r d e l i v e r y o f cholesterol t o extrahepatic tissues (18).
The l e v e l s o f cholesterol, and i n p a r t i c u l a r those o f LDL-cholesterol, i n cord blood of human newborns are much lower than those of adults (10. 15.16 ). However, the l e v e l s o f cholesterol i n plasma r i s e r a p i d l y during the f i r s t few weeks of Dostnatal l i f e I11.12.14. 31) and continue t o r i s e oroaressivelv throughout ad"1thood i n t o middle age (19) . It has been t i a t the " r i s e i n cholesterol l e v e l s a f t e r b i r t h was due t o the comnencement of o r a l feeding and thus was a t t r i b u t a b l e t o d i e t a r y cholesterol. As a straightfolnard extrapolation o f these findings, i t might have been anticipated t h a t during human fetal development, plasma cholesterol l e v e l s e a r l y i n gestation would be lower than those found a t term and would r i s e progressively throughout i n t r a u t e r i n e l i f e . However, Ginsberg and Zetterstrom (12) and Anderson and Friis-Hansen (2) found t h a t cholesterol levels i n f e t a l plasma before 37 weeks of gestation were higher than those present a f t e r t h i s time o f gestation.
Several investigators (4.10. 15.16) have attempted t o ascertain whether levels of cholesterol and lipoproteins i n cord plasma o f term newborns were p r e d i c t i v e of a predisposition t o hypercholesterolemia o r cardiovascular disease i n l a t e r l i f e . Such e f f o r t s have met w i t h l i t t l e success. One reason for t h i s f a i l u r e i s t h a t the steroidogenic a c t i v i t y o f the fetal adrenals appears t o be an important determinant o f the l e v e l s o f LDL-cholesterol i n human fetal plasma. The human f e t a l adrenals synthesize l a r g e quantities of s t e r o i d hormones, p a r t i c u l a r l y dehydroisoandrosterone s u l f a t e (DS) which, i n turn, serves as precursor f o r placental estrogen formation (27) . One major source o f precursor f o r human f e t a l adrenal steroidogenesis appears t o be LDL-cholesterol i n f e t a l plasma (5. 6.23) .
W e have shown previously t h a t an inverse r e l a t i o n s h i p e x i s t s between the steroidogenic a c t i v i t y o f the f e t a l adrenals and the concentration o f t o t a l -and LDL-cholesterol i n the f e t a l plasma of term infants born of normal and complicated pregnancies (23). Furthermore, the aforementioned r a p i d r i s e i n plasma cholesterol during the f i r s t few weeks o f postnatal l i f e i s correlated well with the r a p i d i n v o l u t i o n of the fetal zone of the adrenal cortex (26, 28) . I t i s l i k e l y , therefore, t h a t the r a t e of steroidogenesis by the human f e t a l adrenal glands i s an important determinant of the levels of cholesterol i n human fetal plasma. Conversely, the a v a i l a b i l i t y of c i r c u l a t i n g cholesterol i n the fetus may play an important r o l e i n pregnancy-maintenance, by means of serving as substrate for adrenal steroidogenesis, i n addition t o i t s importance i n the orderly growth and development o f the fetus. For these reasons we sought, i n the present study, t o define the developmental changes i n the l e v e l s of cholesterol i n human f e t a l plasma throughout normal gestation.
MATERIALS AND METHODS
The study group consisted of abortuses of women undergoing e l e c t i v e abortion f o r socio-economic reasons ( < 22 weeks post-conception), i n f a n t s o f women who underwent spontaneous premature vaginal delivery, and infants of women who delivered vaginally a t term. No cases t h a t involved complicat i o n s o f d e l i v e r y (other than prematurity), maternal i l l n e s s , fetal abnormal i t i e s , o r m u l t i p l e b i r t h s were included i n t h i s study. A l l newborns were judged t o be normal based upon the findings of a thorough examination a t d e l i v e r y and abortuses were judged t o be normal based upon findings a t autopsy. Umbilical cord blood samples o f abortuses were obtained i n accordance w i t h the Donors Anatomical G i f t Act o f the State of Texas a f t e r consent i n w r i t i n g from the women t o be aborted was obtained. A consent form and and protocol approved by the Human Research Review Committee o f the University o f Texas Health Science Center a t Dallas, Dallas, Texas was used i n the case o f umbilical cord blood samples from newborns.
Umbilical cord blood samples ( f e t a l portion of cord) were obtained w i t h i n 1-3 minutes a f t e r d e l i v e r y w i t h the exception o f a few instances wherein blood was obtained from fetuses w i t h i n 20 minutes a f t e r abortion hysterectomy. I n order t o prevent possible contamination of f e t a l blood by maternal blood, the umbilical cord was doubly clamped, rinsed, severed, and blood was then c o l l e c t e d d i r e c t l y by c a p i l l a r y flow i n t o heparinized microhematocrit tubes ( S c i e n t i f i c Products) and centrifuged i n a micro-capillary centrifuge (IEC Model ME). Otherwise, blood was drained from the umbilical cord i n t o tubes t h a t contained EDTA as anticoagulant. Plasma was collected following c e n t r ifugation. A l l plasma samples were stored a t 4 "C and were analyzed w i t h i n one week o f collection. The analysis f o r t o t a l cholesterol was conducted by use of a Beckman Cholesterol Analyzer 2 (Beckman Instruments, Inc.), according t o a modified microenzymatic method based upon oxygen consumption (3). With t h i s method, o n l y 5-10 p1 o f plasma i s required. Normally, samples were analyzed i n duplicate, but sometimes, as i n many cases i n the samples of the < 22 weeks gestational age group, i t often was possible t o analyze only a single a l i q u o t because of the small volume o f plasma collected. No systematic difference i n cholesterol l e v e l was noted between blood samples collected i n heparinized tubes and those collected i n tubes containing EDTA. The i n t e rassay c o e f f i c i e n t o f v a r i a t i o n for cholesterol l e v e l s i n a pool o f cord plasma was 4.1%. The intraassay c o e f f i c i e n t of v a r i a t i o n f o r plasma samples w i t h cholesterol concentrations ranging from 40 t o 200 mgldl was found consistently t o be less than 10%. As a t e s t o f the accuracy of the method, a pool of cord plasma derived from normal newborns delivered of normal mothers a t term was assayed w i t h t h i s technique and also assayed by another laboratory using a modification o f the Liebermann-Burchard method (30) . The cholesterol l e v e l s t h a t we obtained w i t h the Beckman Cholesterol Analyzer 2 and the microenzymatic method (48.7 t 4.7 mg/dl, mean t SD) were s i m i l a r t o those obtained using t h i s other method (49.9 t 0.7 mgldl).
Data for several gestational ages (weeks post-conception) were grouped and were analyzed using the Mann-Whitney U test. Differences between groups were considered t o be s i g n i f i c a n t a t P < 0.05.
RESULTS
The
Between the gestational ages of 10 and 16 weeks post-conception, the t o t a l cholesterol concentration i n umbilical cord plasma ( n = 68) was 85.4 ? 30.7 mgldl (mean + SD), w i t h the cholesterol concentrations i n some individual samples being as great as 140 mgldl. At l a t e r gestational ages the l e v e l s of cholesterol were s i g n f i c a n t l y less (P < 0.001), viz., 39.9 + 21 .0 mg/dl between 16.5 and 20 weeks postconception (n = 1 9 r S t i l l l a t e r i n gestation, the plasma cholesterol l e v e l s were higher, v&., t o 40 weeks (n = 44), were 51.4 t 11.5 mgldl, a value s i g n i f i c a n t l y lower (P < 0.03) than t h a t observed between 26.5 and 32 weeks of gestation.
DISCUSSION
I n the current study, we found marked fluctuations i n f e t a l plasma cholesterol l e v e l s during gestation. Although a potential influence of the made of d e l i v e r y on the observed l e v e l s of cholesterol during various gestat i o n a l periods cannot be t o t a l l y r u l e d out, we propose t h a t the ontogenetic changes i n the l e v e l s o f t o t a l cholesterol i n f e t a l p l a s m l i k e l y are, i n part, r e f l e c t i v e o f the r e l a t i v e rates o f synthesis and u t i l i z a t i o n of cholesterol by the f e t a l l i v e r and adrenal, respectively. W e previously have shown t h a t o f the various organs i n the human fetus, the l i v e r and adrenal synthesize cholesterol a t the highest r a t e (Carr and,Simpson, unpublished observations), whereas the adrenal appears t o u t i l i z e plasma cholesterol, i n the form o f LDL, a t a r a t e greater than any other tissue (6). It follows therefore, t h a t the high concentration o f cholesterol i n f e t a l plasma i n e a r l y gestation may be due t o a r a p i d r a t e of lipoprotein-cholesterol biosynthesis i n the f e t a l l i v e r , which, l i k e the f e t a l adrenal, i s extremely a c t i v e i n the synthesis o f cholesterol (13.29).
Since the umbilical cord was c a r e f u l l y cleansed p r i o r t o blood sampling, i t i s not l i k e l y t h a t d i r e c t contamination o f f e t a l blood by maternal blood occured during these studies.
Coincident w i t h the i n i t i a l f a l l i n cholesterol l e v e l s during the period o f 12 t o 20 weeks post-conception, there i s a 10-fold increase i n the size of the fetal adrenal (28) . The fetal adrenal takes up and degrades LDLcholesterol (6) and the l i b e r a t e d cholesterol i s used i n the synthesis of s t e r o i d hormones, most notably DS ( 5 ) . Thus, the r a p i d growth o f the adrenal and the attendant increase i n steroidogenesis could account f o r the depletion of plasma cholesterol a t mid-gestation.
I n support o f t h i s hypothesis i s the finding t h a t the plasma cholesterol l e v e l s i n prematurely delivered anencephalic newborns, i n whom the adrenal i s atrophied and secretes small quantit i e s of s t e r o i d (23,24), are s i g n i f i c a n t l y greater than i n normal fetuses during t h i s period of development (Parker 3 c., unpublished observations) .
Following a nadir a t 16-20 weeks o f gestation, the plasma cholesterol l e v e l s r i s e through about 32 weeks post-conception. The weight of the fetal l i v e r t r i p l e s between 20 and 32 weeks and thereafter the r a t e o f growth of the fetal l i v e r declines (25) . Thus, the r a t e o f synthesis of lipoprotein-cholesterol during t h i s gestational period l i k e l y exceeds i t s r a t e of u t i l i z a t i o n by the fetal adrenal.
The second decrease i n fetal plasma cholesterol l e v e l s i s t h a t which occurs near term. A s i m i l a r decline i n plasma cholesterol levels near term has been documented by others (2.12).
This progressive f a l l i n fetal plasma cholesterol might be explained by the accelerated u t i l i z a t i o n of cholesterol by the f e t a l adrenals t h a t are enlarging r a p i d l y a t t h i s stage of gestation, a time when the r a t e o f growth o f the f e t a l l i v e r i s declining. Coincident w i t h the decline i n f e t a l plasma cholesterol l e v e l s during the l a s t few weeks o f gestation there i s a marked increase i n the l e v e l of e s t r i o l i n maternal plasma (9.17).
E s t r i o l i s synthesized i n the placenta p r i n c i p a l l y from fetal p l a s m I&-hydroxydehydroisoandrosterone s u l f a t e which, i n turn, i s formed from DS secreted by the f e t a l adrenal (27) . Consistent w i t h the hypothesis t h a t the progressive decline i n fetal plasma cholesterol levels near term i s due t o accelerated clearance of LDL-cholesterol through fetal adrenal u t i l ization i n s t e r o i d formation are the findings o f Parker 3 c. (23). They found t h a t the concentrations o f t o t a l and LOL-cholesterol i n plasma of term newborns were r e l a t e d inversely t o the umbilical cord plasma concentration o f the f e t a l adrenal estrogen precursor, i.e., DS. I n addition, exceptionally high levels of cholesterol and very low l e v e l s o f DS were found i n plasma of anencephalic newborns de1:vered a t term (23. 24 ).
An analogous s i t u a t i o n has been observed i n the case of adults. L e i t c h t e r and Daughaday reported the finding of massive steroid secretion and severe hypocholesterolemia i n a woman w i t h a large, benign adrenal adenoma (21) 
The cholesterol concentrations i n umbilical cord plasma of normal newborns near term t h a t we found i n the current study are lower than those reported by other investigators (4,10,11,14,15).
A1 though i t i s known t h a t the several methods for cholesterol determination are variably affected by many factors ( l a ) , we conclude t h a t the difference between our r e s u l t s and those o f others i s not a t t r i b u t a b l e wholly t o methodological differences.
The newborns from whom plasma was obtained i n t h i s study as well as t h e i r mothers were screened c a r e f u l l y t o exclude any abnormal newborn and any mothers w i t h medical complications. Others have reported unexplained elevations i n cholesterol and t r i g l y c e r i d e levels i n newborns delivered o f women w i t h c e r t a i n complications of pregnancies (1, 8) and i n newborns o f women treated w i t h betamethasone (2). Furthermore, we have shown previously t h a t maternal chronic hypertension, pregnancy-induced hypertension, and diabetes are associated w i t h elevations i n cord plasma l e v e l s o f t o t a l and LDL-cholesterol, presumably as the r e s u l t of depressed u t i l i z a t i o n o f LDL-cholesterol by the f e t a l adrenal as steroid substrate (23.24). The blood samples obtained from newborns between gestational ages 24 and 36 weeks were from pregnancies del i v e r e d a f t e r the spontaneous onset o f premature labor i n otherwise normal pregnant women. This group of newborns was chosen since, as c i t e d above, i t i s known t h a t the plasma cholesterol values are a l t e r e d i n newborns o f mothers w i t h complications o f pregnancy t h a t threaten f e t a l we1 1 -being. W e cannot be sure t h a t spontaneous premature labor i s not associated w i t h a l t e r a t i o n s i n fetal plasma cholesterol levels. However from the findings o f t h i s study i t i s c l e a r t h a t the cholesterol levels i n infants born prematurely are lower than i n those e l e c t i v e l y delivered prematurely because o f maternal disease (Parker Gal., unpublished observations).
I n sumnary, cholesterol l e v e l s i n human fetal plasma e a r l y i n gestation are extremely high, compared t o those found a t t e n . Indeed the concentration o f cholesterol e a r l y i n gestation i s s i m i l a r t o t h a t found i n adults. Subsequently cholesterol l e v e l s i n f e t a l plasma f a l l u n t i l 20 weeks post-conception. This nadir i n fetal plasma cholesterol l e v e l s i s followed by a secondary r i s e and thence a second decline beginning a t about 30 weeks post-conception and p e r s i s t i n g u n t i l term. These changes i n fetal plasma cholesterol l e v e l s may be explained, i n part, by a l t e r a t i o n s i n the r a t e of biosynthesis o f l i p oprotein-cholesterol, presumably i n the fetal l i v e r , and by the r a t e o f LDL clearance from plasma p r i n c i p a l l y by the f e t a l adrenal wherein cholesterol i s u t i l i z e d as substrate for the biosynthesis of large amounts of steroids, p a r t i c u l a r l y DS. 
